Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.

ChemGenes Corporation, a biotechnology company, recently relocated to a state-of-the-art facility in Wilmington, Massachusetts. They have consistently been a strong partner to researchers engaged in the field of DNA/RNA synthesis for 36 years. By starting out as a supplier of ‘Ultra Pure Products’ and then by becoming an active Contract Researcher, ChemGenes Corporation has achieved unparalled expertise in the field of DNA/RNA synthesis. Thus, all of us at ChemGenes have the opportunity and great pleasure to serve a vast number of scientists in the US and all over the world.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Alida Biosciences, Inc. is a company headquartered in San Diego, CA. The firm operates as a biotech company creating RNA analysis tools to improve human health. Gudrun Stengel is the current CEO of the firm.

Active Motif, Inc. develops and distributes molecular biology-based research tools and kits that help researchers elucidate the function, regulation and interactions of the genes and their encoded proteins. Its products include New TransAM, Methylated Histones, and Histone Purification Mini Kit. The company was founded in 1999 and is located in Carlsbad, CA.

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Pharmaceutical research company

Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.

Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany.

Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic high-definition mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to receive a “1000 Genome” award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis. It was founded in 2004 and headquartered in Providence, Rhode Island.

Nabsys 2.0 LLC is a company headquartered in Providence, RI, that provides accurate analysis of genomic structural information services. The firm was founded in 2015 by Barrett W. Bready, who has been the CEO since the company founding.\nThe company says this about itself: High-Definition Mapping, HDM? employs reusable, semiconductor-based chips to provide routine, accurate, cost-effective analysis of genomic structural information. These characteristics make HDM an ideal first-line approach for a variety of applications for small and large genomes, including genome assembly, structural variant analysis, and strain identification. The HD-Mapping system is a total whole-genome mapping solution including the HD-Mapping instrument, electronic nanodetector chips, sample-preparation kits, run reagents, and advanced analytical software tools.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Ohara Pharmaceutical Co., Ltd. manufactures, distributes, imports, and exports pharmaceuticals and related food additives. It also specializes in orphan drugs for Leukemia, Leukocytpenia, stem cell transplantation, and Parkinson's disease. The company was founded on November 5, 1964 and is headquartered in Koka, Japan.

Guangzhou Codon Gene Technology Co., Ltd., established on 2016-09-07, Business scope includes biotechnology extension services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;New material technology promotion service;New material technology development service;New material technical consultation,communication service;New material technology transfer service;Natural science research and experimental development;Human Science Research,to develop;Health Sciences Program Research,to develop;Stem Cell Technology Research,to develop;Medical Research and Experimental Development;Gene drug development;Engineering and Technology Research and Experimental Development;Wholesale of chemical products(Excluding hazardous chemicals);Commodity wholesale trade(Except for licensed and approved products);Instrument wholesale;

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

China Phosphorus Technology (Shenzhen) Co., Ltd., established on 2021-08-20, Business scope includes general business items:R&D and application of cell technology;Biochemical product technology research and development;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Biomass Energy Technology Services;Sales of Class I Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Jewelry Retail;Wholesale Jewelry;Jewelry Manufacturing;Jewelry Recycling Repair Service;Research and development of special electronic materials;Sales of power electronic components;Electronic special equipment manufacturing;Sales of special equipment for semiconductor devices;Manufacturing of Special Equipment for Semiconductor Devices;Quantum Computing Technology Services;Resource recycling technology research and development;Emerging energy technology research and development;IoT application service;internet data service;Internet of Things Technology Services;5GCommunication Technology Services;Industrial Internet Data Service;Internet of things technology research and development;Machinery sales;General machinery and equipment installation services;Instrument Repair;AI Hardware Sales;electronics sales;sales agent;internet sales(Except for products that require a license for sale);Information Technology Consulting Services;Big data service;Network technology service;Computer System Services;Information system integration service;Information system operation and maintenance services;software development;Software outsourcing service;IC sales;Integrated circuit chips and product sales;Industrial Robot Sales;software sales;IoT Device Sales;Digital culture creative software development;electronic,Mechanical equipment maintenance(No special equipment);Manufacturing of electronic components and electromechanical components.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:none

Guangzhou Jisai Biotechnology Co., Ltd., established on 2010-06-08, The scope of business includes the manufacture of special equipment for teaching;Health Sciences Program Research,to develop;Medical Research and Experimental Development;Gene drug development;Stem Cell Technology Research,to develop;Natural science research and experimental development;Human Science Research,to develop;Instrument wholesale;Commodity wholesale trade(Except for licensed and approved products);Wholesale of chemical products(Excluding hazardous chemicals);Biotechnology Consulting,communication service;Biotechnology Development Services;Biotechnology Transfer Services;Biotechnology Extension Services;Engineering and Technology Research and Experimental Development;Manufacturing of experimental analysis instruments;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);New material technology development service;New material technical consultation,communication service;New material technology transfer service;trade agent;Commodity retail trade(Except for licensed and approved products);Trade Advisory Services;Import and export(Excluding franchised products);Technology Import and Export

Zhenjiang Yongchen Technology Co., Ltd., established on 2021-09-13, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Pharmaceutical commissioned production;Research and development of bio-based materials technology;Graphene Material Sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of ecological environment monitoring and testing instruments;Sales of bio-based materials(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Eclipse Bioinnovations is a leading RNA genomics company founded in 2017 based on technology developed at the University of California, San Diego. Eclipse's mission is to use their pioneering RNA genomics platform technologies to advance RNA medicines and scientific discovery. Eclipse’s founders developed eCLIP, the world’s most efficient and unique CLIP-seq technology for identifying RNA binding protein gene partners and gene maps. Eclipse’s suite of RNA genomics technologies now cover eCLIP-RBP for mapping the RNA binding proteins, miR-eCLIP for the miR-interactome, m6A-eCLIP for RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for simplifying Crispr library prep. Products are offered as services and kit for biopharma companies and academic researchers, and can be customized for clients.

Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom.